Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma

Publisher： John Wiley & Sons Inc

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.7, 2015-04, pp. : 1128-1137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I Trial of Gemcitabine Dose Escalation with Concurrent Radiotherapy for Patients with Locally Advanced Pancreatic Cancer

By  

Pancreatology, Vol. 10, Iss. 1, 2010-03 ,pp. : 60-65

Karger

Access to resources Recommend Favorite

Phase I Dose-Finding Study of Vandetanib in Combination with Gemcitabine in Locally Advanced Unresectable or Metastatic Pancreatic Adenocarcinoma

By  

Oncology, Vol. 81, Iss. 1, 2011-09 ,pp. : 50-54

Karger

Access to resources Recommend Favorite

Clinical outcomes of carbon ion radiotherapy for locally advanced adenocarcinoma of the uterine cervix in phase 1/2 clinical trial (protocol 9704)

By  

CANCER, Vol. 120, Iss. 11, 2014-06 ,pp. : 1663-1669

John Wiley & Sons Inc

Access to resources Recommend Favorite

Updated long‐term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010

By  

CANCER, Vol. 119, Iss. 23, 2013-12 ,pp. : 4196-4204

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intensified Neoadjuvant Chemotherapy with Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX in a Patient with Locally Advanced Unresectable Pancreatic Cancer

By  

Case Reports in Oncology, Vol. 7, Iss. 3, 2014-09 ,pp. : 648-655

Karger

Access to resources Recommend Favorite